Condition: Intracranial Hypertension · Traumatic Brain Injury · Subarachnoid Hemorrhage · Sponsor: University of Milano Bicocca
The new Integra CereLink ICP monitor integrate the possibility of recording and displaying continuously the AUC (Pressure Time Dose, PTD) and other ICP derived variables and provide the possibility of evaluating the utility of this information at the bedside. It offers the opportunity to test in a standardized way the clinical value of the PTD computation in this setting. Therefore, this study aims to test clinically if PTD recorded continuously is associated to patients' outcome and to identify a threshold of PTD associated with the transition from good to negative outcomes.
This description comes directly from the study's public registry record.
Giuseppe Citerio, Professor · +39039233 · giuseppe.citerio@unimib.it
Always discuss trial participation with your own doctor first.
| Fondazione IRCCS San Gerardo dei Tintori | Monza, MB, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04459806